Community Pharmacy IT Group (CP ITG) workstream updates

Published on: 28th June 2021 | Updated on: 1st June 2026

Read more about CP ITG and its work at: the Community Pharmacy IT Group (CP ITG) webpage.

This ‘CP ITG workstream update‘ webpage sets out information following CP ITG meetings based on the the latest pharmacy IT bulletin.

The latest bulletin can also be downloaded in pdf format: CP ITG Summer 2026 IT bulletin (pdf)


Workstreams (overview)

CP ITG has five workstream areas:

  1. Interoperability and security: Ensuring information about people’s health and care can be safely and securely accessed, wherever it is needed. (WS1a-1d)
  2. Reducing burden: Use of digital to reduce the burden on pharmacy teams, so they can focus on patients, and appropriate infrastructure for the task. (WS2a)
  3. Good use of digital: Support the use of digital within pharmacy to improve health and care productivity, improve patient safety outcomes and improve cooperation between pharmacy teams and the health and care system. (WS3a-3c)
  4. Patient and pharmacy tools: Support enabling patients to be able to choose digital tools to access medicines information and pharmacy services directly, so they can receive the best outcomes, recognising the need to also remain inclusive for all patients. (WS4a)
  5. Set out roadmap priorities: Development and promotion of a wider community pharmacy digital roadmap / vision. (WS5a)

See downloadable PDF version of the full: CP ITG workstreams.

These sections below set out updates related to these workstreams based on the most recent pharmacy IT bulletin.

Community pharmacy IT developments: overview

CP ITG pharmacy representative priorities: CP ITG Roadmap

The group’s next steps and roadmap working documents have received more updates since the last meeting:

The theme across pharmacy requests for IT change, is in line with the 10 Year Health Plan for England, relating to a desire for the ‘seamless flow of clinical information’ (interoperability). A more seamless flow of clinical information would also help to realise Nuffield Trust’s vision for the sector, with it being able to support continuous improvement:

  • preventing ill health and supporting wellbeing;
  • providing clinical care for patients;
  • helping patients to live well with medicines; and
  • provision of integrated primary care for neighbourhoods.

The updated positions are shared with NHS England.

Overview of current pharmacy IT priorities

NHS England, the Department of Health and Social Care, and CP ITG have identified a set of key IT priorities for community pharmacy. These include:

  • IT to support the development of the Community Pharmacy Contractual Framework (CPCF);
  • electronic health records;
  • service data APIs;
  • Booking and Referral Standards (BaRS); and
  • the next generation of EPS.

CP ITG continues to support these programmes, with Community Pharmacy England working alongside NHS England to help shape and advance this work. These priorities align with the group’s working document on CP ITG’s vision of pharmacy IT and with the wider ambitions for community pharmacy set out in the Nuffield Trust and King’s Fund vision.

NHS England also continues to develop the framework to incentivise the development of community pharmacy IT system suppliers, aligned with the CPCF. This includes supporting an open supplier market and involving both pharmacy teams and suppliers in shaping requirements. NHS England’s Transformation Directorate is working to support suppliers in transitioning to the NHS Digital Services for Integrated Care (DSIC) framework.

NHS England has been working with both existing assured service suppliers and prospective suppliers progressing through the DSIC assurance process. Suppliers have continued DSIC‑related work, with further activity expected over the course of this year as the DSIC pharmacy workstream progresses in line with planned timelines.

EPS updates:

EPS technology upgrades: Transitionary work continues with EPS FHIR architecture modernisation for EPS (Project FAME). This modernisation work aims to strengthen long‑term interoperability, improve resilience and usability, and support future enhancements that benefit patients and pharmacy teams.

Better visibility of repeat medicines in the NHS App: Changes are being made with NHS App prescriptions features so that they give patients a more complete view of all their active repeat medicines. Patients can now see all their repeat items in one place, including medicines that cannot be requested yet, with clear explanations of why, for example, if it’s too soon to order again, or a review is needed. This helps people better understand their medicines, and reduces the confusion where items previously appeared “missing”. All TPP practices are now live with this feature, with Optum (formerly known as EMIS) practices rolling out from June.

EPS nomination: NHS England updated its national EPS nomination standards on how pharmacy teams and IT system suppliers process EPS nominations. The drafted version had been discussed at the group’s previous meeting. This follows renewed scrutiny of nomination practices and reinforces the principle that patients must be able to set or change their nomination freely, without pressure or unwanted intervention.

Other projects continue:

  • NHS App notifications
  • EPS Prescription Tracker version 2.0

Medicine pack barcode data quality

Following past discussion of this, the Medicines and Healthcare products Regulatory Agency continue to be made aware of concerns about the limited availability and consistency of Global Trade Item Numbers (GTINs) and the declining presence of 2D data matrix barcodes on UK‑only medicines packs.

CP ITG feedback has continued to be shared to NHS England.

Two related issues:

  1. GTINs and the medicines licensing process: GTINs are widely used within clinical systems to support medication safety, stock management and digital dispensing. However, GTINs are not currently incorporated into the medicines licensing process and are not included within Summary of Product Characteristics (SmPCs). This results in NHS systems relying on voluntary manufacturer submissions, leading to gaps, errors, and inconsistencies.
  2. Reduced use of 2D data matrix barcodes on UK packs: Following changes under the Windsor Framework, 2D barcodes are no longer mandatory for UK‑only medicines. The NHS is now seeing a growing number of packs arriving without these barcodes, which undermines safety and efficiency initiatives such as Scan4Safety and closed‑loop medicines processes.

MHRA and others are being asked to consider adding GTINs to the medicines licensing process and to mandate 2D barcodes on UK medicine packs (containing the GTIN, batch number, and expiry date). Some representatives have noted that achieving consistency may require legislative or regulatory change.

Group actions:

  • NHS England is inviting pharmacy team members and CP ITG representatives to complete a short survey on the impact of incomplete or inaccurate barcode data on patient safety and day‑to‑day workflows.
  • Pharmacy representatives that need to, can make use of a form to complete that helps GS1 and others understand the scale and types of issues.

Guidance on ambient scribing tools

Community Pharmacy England has published a new webpage on ambient scribing tools, setting out how they may support community pharmacy, and the safeguards required for their use.

Ambient scribing tools use voice technology and AI to create draft consultation notes, which pharmacy professionals must review and approve. This can help reduce administrative workload, improve record quality, and allow greater focus on patient care.

These tools are particularly relevant as community pharmacies deliver more clinical services. However, they must be used safely, transparently, and in line with NHS guidance.

Ambient scribing tools do not replace professional judgement, do not make clinical decisions, and do not automatically update patient records. Pharmacy teams remain fully accountable for all documentation. Overall, these tools offer potential efficiency benefits but require careful and responsible implementation.

The NHS digital Ambient scribing webpage states that:

“Applications for [IT] suppliers reopened on 3rd February 2026 and will remain open. Read more about the process on the Find a Tender website. The list of suppliers on our website will be updated when new suppliers are added to the list of self-certified AVT supplier.”

IT system selection

NHS England researchers are seeking pharmacy input on how clinical IT systems are chosen and compared (e.g. the Pharmacy First system). And what pharmacy teams might want to know ahead of such decisions.

This important 5-minute survey helps pharmacy owners and decision-makers shape future approaches around clarity, usability, and reducing burden.

Group actions:

  • Pharmacy representatives are encouraged to complete the survey.
  • The group are encouraged to share this for their networks to complete it.

Local IT roadmaps and ICB IT priorities 

Community Pharmacy England has recently received queries from Local Pharmaceutical Committees (LPCs) about Integrated Care Boards (ICBs) asking for views on local community pharmacy IT priorities and digital investment plans.

To help support these local conversations, we have updated the IT policy webpages with a template:

Local pharmacy IT priorities and ICBs

The template is designed to help LPCs and pharmacy owners:

  • Articulate community pharmacy IT priorities in a clear and consistent way
  • Align local asks with wider ICB and primary care digital objectives
  • Support constructive discussions about inclusion of pharmacy within local digital plans and local digital proposals
  • Reduce duplication and variation across different ICB areas

The content draws on CP ITG principles and existing national pharmacy IT priorities, while remaining flexible for local use. It is intended as a starting point rather than a fixed or mandatory position.

We are keen to ensure this resource, primarily aimed at LPCs is practical, proportionate, and genuinely helpful at local level.

Group action:

LPCs, pharmacy owners, and other stakeholders are therefore invited to share feedback on the working document with da@cpe.org.uk following the meeting.

Systems & services IT

Ambient scribing tools updates

Artificial Intelligence (AI) regulation

Artificial Intelligence (AI) pilot and trials

Artificial Intelligence (AI) and health

Vaccination IT

nhs.net

Data flow, standards & IT communications

Community pharmacy and GP co-working

NHS England previously announced changes to the GP Contract in 2026/27, which included digital elements to support co-working. Supplementary information to support changes to the 2026/27 GP contract was updated in May 2026 regarding the below.

2.12 Ensuring patient choice of pharmacy

In the letter announcing the changes to the GP contract we said the practices would be required to reconfirm the nominated pharmacy, whenever a new (non-repeat) prescription is issued – and to ensure that any referral and triage tools used for community pharmacy clinical services offer patients a full choice of provider.

By this we mean that patients must be able to choose, and if they wish, nominate or change their NHS community pharmacy of choice, for electronic transfer of prescriptions or referral for clinical services. Practices must provide clear, accessible information on how patients can nominate or change their chosen pharmacy. Patients should be given unbiased information, free from any influence towards a particular pharmacy.

Any triage or referral tools used by the practice to support access to community pharmacy clinical services must present the full list of available NHS community pharmacies, enabling patients to make an informed choice from all suitable providers. Practices are responsible for ensuring that digital and non-digital referral processes do not restrict patient choice.

2.13 Dedicated GP email address for community pharmacy communication

In the letter announcing the changes to the GP contract we said that practices will be required to have a dedicated, monitored email address. It will be for receiving information from community pharmacies in the event that GP connect is unavailable and for new or emerging pharmacy activity that is not yet supported through GP Connect (for example, independent prescribing in community pharmacy).

By this we mean that practices must maintain a suitable, monitored and secure email (The secure email standard – NHS England Digital, Secure Email – NHS Standards Directory) address to support safe and effective communication with community pharmacy. The purpose of this requirement is to support coordination of care, manage referrals, and ensuring accurate prescription handling where alternative digital routes are not available.

Practices are not required to create a new email address where existing secure email addresses fulfil this function. The email address must be regularly monitored during core practice hours to ensure timely review, and where needed, response. Practices are required to record this email address and keep it up to date in the NHS Directory of Service. Practices and community pharmacies are jointly responsible for maintaining confidentiality and data security in all email exchanges.

Interoperability

As part of NHS England’s digital transformation and transition into the Department of Health and Social Care, a review of legacy digital services has been undertaken. Following this review, developer.nhs.uk and associated domains will be decommissioned on 2 March 2026.

This includes the FHIR servers:

Key developer content is being migrated to new locations or archived for reference. Suppliers, developers, and programme teams should update any documentation, integrations, or bookmarks accordingly.

FHIR assets previously hosted on these servers are now available at the following locations:

Further details are available on the Decommissioning developer.nhs.uk and FHIR servers page.

SNOMED International Proposal to Increase Description Length Limit

NHS England has provided an update to the information shared in September 2025 regarding SNOMED International’s proposal to increase the maximum length of Fully Specified Name (FSN) and Synonym descriptions from 255 to 4,096 characters.

Additional information has now been released by SNOMED International and is available in the following document: Transition Plan to Increase Description Type Length Limits.

A blog containing further details is also available on the SNOMED International website.

If pharmacy or supplier representatives have any questions or concerns, please contact support.digitalservices@nhs.net, quoting ‘SNOMED International proposal to increase Description length limit’ in the subject line.

NHS England will continue to share updates from SNOMED International as they become available.

Updating the SNOMED CT UK Drug Extension Model: Phase 3 and Phase 4 Changes

NHS England provided an update to the information published in March regarding the planned Phase 3 and Phase 4 changes to the SNOMED CT UK Drug Extension.

NHS England had previously planned to implement these changes as a joint release (version 42.1.0) in May 2026.

Further information about this work is available on the NHS England webpage.

If you would like to discuss this work further, please contact: nhsdigital.ukmeds@nhs.net.

Digital patient services & prescriptions

NHS account and NHS App updates

NHS POC codes

  • Community Pharmacy England published guidance for pharmacy owners with more than one premises: Knowing your NHS POC code
  • Every community pharmacy owner has an NHS Parent Organisation Code (POC).
  • This is the unique code that identifies the pharmacy premises ‘parent organisation’ within the NHS.
  • If pharmacy owners have a single pharmacy, they still have a POC.
  • If pharmacy owners own multiple pharmacies, each pharmacy site should be correctly linked to the same POC.
  • POCs are usually four or five characters long and often begin with the letter “P”.
  • Getting this right is important. It helps ensure NHS records about pharmacy organisations are accurate and consistent.
  • POCs differ to the unique ODS code of a pharmacy. ODS codes have five characters – usually starting with ‘F’.

Read more: Knowing pharmacy NHS POC codes.

Patient tools

  • HSJ opined that NHS England may be:
    • concerned about £11m being associated with supporting patient engagement portal supplier platforms; and
    • looking at speeding up the work towards directly integrating appointment management into the NHS App.

Patient tools: guidance on sending NHS-related notifications to patients

NHS England has published new messaging best practice guidance alongside a content guide for writing and sending messages via the NHS App, text messages, emails and letters. The guidance supports teams across the NHS to create clearer, safer and more effective communications for patients and the public.

It covers when and how to contact patients, the benefits of a digital‑first approach, and practical advice on getting started with NHS Notify, the national NHS messaging service. This encourages those who will use it in future to explore the guidance to strengthen their messaging and help improve patient outcomes. The group previously discussed the need for future standardised pharmacy notification wording for relevant scenarios and where appropriate.

Read the Messaging Best Practice Guidance and use the Writing NHS Messages Content Guide.

Electronic health records

Records

Single Patient Record developments

The Department of Health and Social Care (DHSC), NHS England, and Health Minister Karin Smyth have outlined key changes in the NHS Modernisation Bill.  A central feature of the bill is the introduction of the Single Patient Record (SPR).

This will require all NHS providers—including hospitals and GP practices—to share patient data, enabling authorised doctors, nurses and specialists across England to securely access a patient’s full medical history, regardless of where they receive treatment.

The SPR will be a secure, digital system that intends to bring together patient health information in one accessible place. It is intended to support safer, faster and more coordinated care by ensuring health and care professionals have the information they need when they need it.

Clinicians are expected to start benefiting from improved access to records as early as 2027, beginning with areas such as maternity and frailty care.

Read more: the new SPR factsheet and SPR.

Connectivity & data security

Policy and general updates

IT policy: priorities, reports and the future 

IT policy: commentary and requests for the future 

Digital inclusion

Digital capabilities of the workforce

Referrals & appointments

Optimal principles across all pharmacy IT

  • Pharmacy teams can provide updates about any efforts to move towards more paperless work by contacting da@cpe.org.uk.

Additional archived quarterly updates

See: CP ITG workstream updates (archive) for older updates in html format. The bulletins (including the most recent one) can also be downloaded in pdf format at the CP ITG webpage.

Get involved

If you have a related query or would like to feed into the CP ITG or share your updates about IT and digital issues then please don’t hesitate to contact one of the group’s organisers, Dan Ah-Thion or it@cpe.org.uk or you can also sign-up to join the virtual Community Pharmacy Digital Group which helps inform CP ITG’s work with others. You can be involved as much or as little as you like with CPDG, and can unsubscribe from that email group at any time.

Return to the Pharmacy IT hub; CP ITG; Get involved; IT policy or IT a-z index

For more information on this topic please email it@cpe.org.uk

Latest Digital & Technology news

View more Digital & Technology newsSee all